Research presented during the Pediatric Academic Society (PAS) 2018 Meeting suggests that when it comes to decision-making about hormone therapy (HT), transgender teens and their parents may have different views about preserving biologic fertility.
©Andrii Zastrozhnov/shutterstock.com
Research presented during the Pediatric Academic Society (PAS) 2018 Meeting suggests that when it comes to decision-making about hormone therapy (HT), transgender teens and their parents may have different views about preserving biologic fertility.
Included in the study, by researchers from Children’s Hospital of Philadelphia, were 66 youth and 52 parents who obtained medical care at a pediatric hospital-based clinic for transgender/
gender non-conforming (T/GNC) between January 2017 and December 2017. Youth participants were mean age 16 and a majority (63%) of the participants were assigned female sex at birth. The mean age of the parents was 48. Both youth and parents completed an electronic 36-item survey with questions about their knowledge of fertility preservation (FP), desire to have biologic children, and other factors that might affect desire to pursue FP.
Only 20% of youth and 11.5% of parents found it important to have biologic offspring. For the youths, the importance of having biologic children was associated with perceiving it as something that was important to their parents (OR = 6.07; 9% CI, 1.28 - 28.7). Only 4.5% of youth agreed that they would be willing to delay HT; the importance of having biologic children was the most important predictor for these youth (OR = 6.76; 95% CI, 1.28 – 28.7).
For parents, the most important predictor for delaying HT was lack of information about whether that treatment definitely prevents biologic fertility (OR = 24.57, 95% CI, 3.9 – 154.15). A significant majority of youth (70%) agreed that discomfort with a part of the body that they didn’t identify with was a factor that influenced their decision to undergo FP.
The findings show that fertility is not a major factor in decision-making about HT for the majority of T/NGC youth and their parents. The researchers believe, however, that their data underscore a need for more research on the impact FP has on biologic fertility so that parents and T/NGC youth can make more informed decisions when considering HT.
For more updates from our August issue:
How should states support pregnant teens?
Teen pregnancy, depression and the Internet
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More